Dr Louise Reynolds

Centre for Tumour Biology
Postdoctoral Research Assistant
This email address is being protected from spambots. You need JavaScript enabled to view it.

Using nanoparticle technology to target tumour blood vessels.

My recent project included understanding the importance of pericyte α6-integrin during physiological and pathological angiogenesis, by utilising PDGFR-BCre;α6 mice.

Currently I am leading a project to examine the utility of nanoparticles that deliver siRNA or drugs directly to blood vessels as a novel cancer therapeutic strategy.

See other researchers working on:

Adhesion and Integrins Angiogenesis
This site uses cookies in order to function properly. By continuing to browse, you agree that we can save them on your device. Privacy Policy.